WitrynaImmutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and … Witryna16 gru 2024 · Immutep Advances IMP761 Manufacturing. December 16, 2024 08:00 ET Source: Immutep Limited. SYDNEY, AUSTRALIA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep ...
Immutep Stock - 2024 investment guide (NASDAQ:IMMP)
WitrynaFor the fiscal year ending Jun 2024 , the consensus EPS* forecast has remained the same over the past week at -0.37 and remained the same over the past month at … Witryna12 kwi 2024 · Imperial Petroleum - IMPP Stock Forecast, Price & News $0.17 +0.01 (+6.25%) (As of 03/24/2024 12:00 AM ET) Compare Today's Range $0.16 $0.17 50-Day Range $0.16 $0.36 52-Week Range $0.15 $1.91 Volume 2.40 million shs Average Volume 6.94 million shs Market Capitalization $24.28 million P/E Ratio 1.21 Dividend … sonic 2 community\u0027s cut download
Immutep Stock (NASDAQ:IMMP), Quotes and News Summary
WitrynaThe 5 analysts offering 12-month price forecasts for Immutep Ltd have a median target of 6.72, with a high estimate of 8.30 and a low estimate of 4.02. The median estimate represents a +286.32%... Witryna18 lis 2024 · Sydney, Australia, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) : Australian biotechnology company Immutep Limite ... R&D, manufacturing, the offering costs and ... Witryna31 mar 2024 · G Medical Innovations was down over 45% after it priced a public offering of 12 million shares, or pre-funded warrants in lieu of such shares, at $0.80 each for about $9.6 million in gross proceeds. sonic 2 community\u0027s cut